Nuffield Departments of Clinical Neurosciences, University of Oxford, United Kingdom.
Ann N Y Acad Sci. 2012 Aug;1265(1):9-24. doi: 10.1111/j.1749-6632.2012.06650.x. Epub 2012 Jul 25.
Feedback control of deep brain stimulation (DBS) in Parkinson's disease has great potential to improve efficacy, reduce side effects, and decrease the cost of treatment. In this, the timing and intensity of stimulation are titrated according to biomarkers that capture current clinical state. Stimulation may be at standard high frequency or intelligently patterned to directly modify specific pathological rhythms. The search for and validation of appropriate feedback signals are therefore crucial. Signals recorded from the DBS electrode currently appear to be the most promising source of feedback. In particular, beta-frequency band oscillations in the local field potential recorded at the stimulation target may capture variation in bradykinesia and rigidity across patients, but this remains to be confirmed within patients. Biomarkers that reliably reflect other impairments, such as tremor, also need to be established. Finally, whether brain signals are causally important needs to be established before stimulation can be specifically patterned rather than delivered at empirically defined high frequency.
深度脑刺激(DBS)的反馈控制具有提高疗效、减少副作用和降低治疗成本的巨大潜力。在这种方法中,根据捕获当前临床状态的生物标志物来调整刺激的时间和强度。刺激可以采用标准的高频刺激,也可以采用智能模式来直接修饰特定的病理节律。因此,寻找和验证合适的反馈信号至关重要。目前,从 DBS 电极记录的信号似乎是最有前途的反馈源。特别是,在刺激靶点记录的局部场电位中的β频带振荡可能捕获了不同患者的运动迟缓性和僵硬性的变化,但这仍需在患者内部进行确认。还需要建立可靠反映其他障碍(如震颤)的生物标志物。最后,在可以进行特定模式的刺激之前,而不是采用经验定义的高频刺激,需要确定大脑信号是否具有因果重要性。